List of Tables
Table 1. Migraine Treatment Medication Market Trends
Table 2. Migraine Treatment Medication Market Drivers & Opportunity
Table 3. Migraine Treatment Medication Market Challenges
Table 4. Migraine Treatment Medication Market Restraints
Table 5. Global Migraine Treatment Medication Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Migraine Treatment Medication Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Migraine Treatment Medication Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Migraine Treatment Medication Product Type
Table 9. Key Companies Time to Begin Mass Production of Migraine Treatment Medication
Table 10. Global Migraine Treatment Medication Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Treatment Medication as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Migraine Treatment Medication Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Migraine Treatment Medication Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Migraine Treatment Medication Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Migraine Treatment Medication Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Migraine Treatment Medication Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Migraine Treatment Medication Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Migraine Treatment Medication Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Migraine Treatment Medication Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Migraine Treatment Medication Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Migraine Treatment Medication Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Migraine Treatment Medication Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Migraine Treatment Medication Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Migraine Treatment Medication Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Migraine Treatment Medication Sales Value by Region (2019-2024) & (%)
Table 27. Global Migraine Treatment Medication Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Migraine Treatment Medication Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Migraine Treatment Medication Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Migraine Treatment Medication Sales Value, (2025-2030) & (US$ Million)
Table 31. GSK Basic Information List
Table 32. GSK Description and Business Overview
Table 33. GSK Migraine Treatment Medication Products, Services and Solutions
Table 34. Revenue (US$ Million) in Migraine Treatment Medication Business of GSK (2019-2024)
Table 35. GSK Recent Developments
Table 36. Pfizer Basic Information List
Table 37. Pfizer Description and Business Overview
Table 38. Pfizer Migraine Treatment Medication Products, Services and Solutions
Table 39. Revenue (US$ Million) in Migraine Treatment Medication Business of Pfizer (2019-2024)
Table 40. Pfizer Recent Developments
Table 41. Novartis Basic Information List
Table 42. Novartis Description and Business Overview
Table 43. Novartis Migraine Treatment Medication Products, Services and Solutions
Table 44. Revenue (US$ Million) in Migraine Treatment Medication Business of Novartis (2019-2024)
Table 45. Novartis Recent Developments
Table 46. Teva Basic Information List
Table 47. Teva Description and Business Overview
Table 48. Teva Migraine Treatment Medication Products, Services and Solutions
Table 49. Revenue (US$ Million) in Migraine Treatment Medication Business of Teva (2019-2024)
Table 50. Teva Recent Developments
Table 51. Sun Pharma Basic Information List
Table 52. Sun Pharma Description and Business Overview
Table 53. Sun Pharma Migraine Treatment Medication Products, Services and Solutions
Table 54. Revenue (US$ Million) in Migraine Treatment Medication Business of Sun Pharma (2019-2024)
Table 55. Sun Pharma Recent Developments
Table 56. Grünenthal Basic Information List
Table 57. Grünenthal Description and Business Overview
Table 58. Grünenthal Migraine Treatment Medication Products, Services and Solutions
Table 59. Revenue (US$ Million) in Migraine Treatment Medication Business of Grünenthal (2019-2024)
Table 60. Grünenthal Recent Developments
Table 61. Endo Pharmaceuticals Basic Information List
Table 62. Endo Pharmaceuticals Description and Business Overview
Table 63. Endo Pharmaceuticals Migraine Treatment Medication Products, Services and Solutions
Table 64. Revenue (US$ Million) in Migraine Treatment Medication Business of Endo Pharmaceuticals (2019-2024)
Table 65. Endo Pharmaceuticals Recent Developments
Table 66. Merck Basic Information List
Table 67. Merck Description and Business Overview
Table 68. Merck Migraine Treatment Medication Products, Services and Solutions
Table 69. Revenue (US$ Million) in Migraine Treatment Medication Business of Merck (2019-2024)
Table 70. Merck Recent Developments
Table 71. Johnson & Johnson Basic Information List
Table 72. Johnson & Johnson Description and Business Overview
Table 73. Johnson & Johnson Migraine Treatment Medication Products, Services and Solutions
Table 74. Revenue (US$ Million) in Migraine Treatment Medication Business of Johnson & Johnson (2019-2024)
Table 75. Johnson & Johnson Recent Developments
Table 76. AbbVie Basic Information List
Table 77. AbbVie Description and Business Overview
Table 78. AbbVie Migraine Treatment Medication Products, Services and Solutions
Table 79. Revenue (US$ Million) in Migraine Treatment Medication Business of AbbVie (2019-2024)
Table 80. AbbVie Recent Developments
Table 81. Abbott Basic Information List
Table 82. Abbott Description and Business Overview
Table 83. Abbott Migraine Treatment Medication Products, Services and Solutions
Table 84. Revenue (US$ Million) in Migraine Treatment Medication Business of Abbott (2019-2024)
Table 85. Abbott Recent Developments
Table 86. Bayer Basic Information List
Table 87. Bayer Description and Business Overview
Table 88. Bayer Migraine Treatment Medication Products, Services and Solutions
Table 89. Revenue (US$ Million) in Migraine Treatment Medication Business of Bayer (2019-2024)
Table 90. Bayer Recent Developments
Table 91. Eli Lilly Basic Information List
Table 92. Eli Lilly Description and Business Overview
Table 93. Eli Lilly Migraine Treatment Medication Products, Services and Solutions
Table 94. Revenue (US$ Million) in Migraine Treatment Medication Business of Eli Lilly (2019-2024)
Table 95. Eli Lilly Recent Developments
Table 96. Kowa Pharmaceuticals America Basic Information List
Table 97. Kowa Pharmaceuticals America Description and Business Overview
Table 98. Kowa Pharmaceuticals America Migraine Treatment Medication Products, Services and Solutions
Table 99. Revenue (US$ Million) in Migraine Treatment Medication Business of Kowa Pharmaceuticals America (2019-2024)
Table 100. Kowa Pharmaceuticals America Recent Developments
Table 101. AstraZeneca Basic Information List
Table 102. AstraZeneca Description and Business Overview
Table 103. AstraZeneca Migraine Treatment Medication Products, Services and Solutions
Table 104. Revenue (US$ Million) in Migraine Treatment Medication Business of AstraZeneca (2019-2024)
Table 105. AstraZeneca Recent Developments
Table 106. Key Raw Materials Lists
Table 107. Raw Materials Key Suppliers Lists
Table 108. Migraine Treatment Medication Downstream Customers
Table 109. Migraine Treatment Medication Distributors List
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Migraine Treatment Medication Product Picture
Figure 2. Global Migraine Treatment Medication Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Migraine Treatment Medication Sales Value (2019-2030) & (US$ Million)
Figure 4. Migraine Treatment Medication Report Years Considered
Figure 5. Global Migraine Treatment Medication Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Migraine Treatment Medication Revenue in 2023
Figure 7. Migraine Treatment Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Triptans Picture
Figure 9. NSAIDs Picture
Figure 10. Others Picture
Figure 11. Global Migraine Treatment Medication Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Migraine Treatment Medication Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Acute Migraine
Figure 14. Product Picture of Chronic Migraine
Figure 15. Global Migraine Treatment Medication Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Migraine Treatment Medication Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Migraine Treatment Medication Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Migraine Treatment Medication Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Migraine Treatment Medication Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Migraine Treatment Medication Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Migraine Treatment Medication Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Migraine Treatment Medication Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Migraine Treatment Medication Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Migraine Treatment Medication Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Migraine Treatment Medication Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Migraine Treatment Medication Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Migraine Treatment Medication Sales Value (%), (2019-2030)
Figure 28. United States Migraine Treatment Medication Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Migraine Treatment Medication Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Migraine Treatment Medication Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Migraine Treatment Medication Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Migraine Treatment Medication Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Migraine Treatment Medication Sales Value by Application (%), 2023 VS 2030
Figure 34. China Migraine Treatment Medication Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Migraine Treatment Medication Sales Value by Type (%), 2023 VS 2030
Figure 36. China Migraine Treatment Medication Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Migraine Treatment Medication Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Migraine Treatment Medication Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Migraine Treatment Medication Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Migraine Treatment Medication Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Migraine Treatment Medication Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Migraine Treatment Medication Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Migraine Treatment Medication Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Migraine Treatment Medication Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Migraine Treatment Medication Sales Value by Application (%), 2023 VS 2030
Figure 46. India Migraine Treatment Medication Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Migraine Treatment Medication Sales Value by Type (%), 2023 VS 2030
Figure 48. India Migraine Treatment Medication Sales Value by Application (%), 2023 VS 2030
Figure 49. Migraine Treatment Medication Industrial Chain
Figure 50. Migraine Treatment Medication Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
